Eleven studies investigated the roles of IGF-1, IGFBP3, and the IGF-I/IGFBP3 molar ratio in the development of HCC (Table 1A), and nine studies assessed the ability of serum IGF1 level to predict the TTP and OS of HCC patients (Table 1B). The gene discussed is IGF1; the disease is hepatocellular carcinoma.